Translate Bio: Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Sep 08, 2021

Translate Bio, a clinical-stage messenger RNA therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening diseases, reported that on September 8, 2021, the Company granted restricted stock units for an aggregate of 54,078 shares of the Company's common stock to twenty new employees.